News & Articles

Biopharma needs informatics platforms that are unified, flexible, and intelligent – ready not just for today’s science, but for what is coming next

New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence

Researchers identify RFP protein as a key driver of fat cell formation, opening paths to future obesity treatments

Explore the future of membrane protein therapeutics with innovative antibody platforms

Don Whitley Scientific reaches milestone showing unwavering commitment to microbiology

Innovative overhead stirring solution has been designed specifically for compatibility with Asynt DrySyn reaction vial inserts

Designed to streamline collaboration across biological research, combining real-time data management, analysis, DNA sequence design, chat and review functions within one intuitive, easy to use system

The American Board of Medical Specialties (ABMS) Portfolio Program will leverage Ovid Synthesis, which now features Wolters Kluwer’s Expert AI, to streamline the continuing certification credit process and fast-track patient improvement initiatives

Developed with leading pharmaceutical partners, SCE QC automates quality control workflows and sets a new standard for stats programming

Simoa HD-X receives MFDS Class I IVD Import Clearance, enabling the first clinical introduction of Simoa technology in Korea

The new subsidiary is expected to accelerate broader adoption of Seegene’s developing solutions, CURECA™ and STAgora™, in Europe

Collaboration unites complementary scientific and technical expertise to provide seamless solutions across the biopharmaceutical value chain

The new PCR test aids in the diagnosis of infectious causes of vaginitis through the detection of bacteria associated with bacterial vaginosis and yeast associated with candida vaginitis

Gentle and rapid detachment of in vitro cultured cells

6,000-square-foot facility enables clinical and commercial process development support to help cell therapy developers transition from research-scale to commercialization

Experts discuss the evolving landscape of clinical mass spectrometry, the impact of automation, challenges in integration, and what the future holds

Myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities

Platform enables direct measure of more than 10,000 proteins in diverse FFPE tissue and tumor samples, integrated multi-omic molecular mapping of tumors

University of Cambridge researcher spotlights a novel radiotracer during ELRIG Drug Discovery 2025

Researchers are uncovering previously unknown sources of PFAS using robotic sample preparation and high-resolution mass spectrometry

Agreement to broaden access, streamline logistics, and reduce variability associated with temperature-sensitive shipping of 3D tissue models, without cryopreservation

Pioneering sustainable laboratory practices

General purpose centrifuges with next-generation natural refrigerant cooling system